A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk

Antithrombotic Effect of Antisense Factor XI Oligonucleotide Treatment in Primates

(2013) Jeffrey R. Crosby et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Bleeding and antidotes in new oral anticoagulants

(2013) Ammar Majeed et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Fibronectin coating of oxygenator membranes enhances endothelial cell attachment

(2013) Christian G Cornelissen et al.   Biomedical Engineering Online

Continuous intravenous anaesthesia with sufentanil and midazolam in medetomidine premedicated New Zealand White rabbits

(2013) Patricia Hedenqvist et al.   BMC Veterinary Research

Development of a Selective Peptide Macrocycle Inhibitor of Coagulation Factor XII toward the Generation of a Safe Antithrombotic Therapy

(2013) Vanessa Baeriswyl et al.   JOURNAL OF MEDICINAL CHEMISTRY

In vivo roles of factor XII

(2012) T. Renne et al.   BLOOD

A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience

(2012) M Pieri et al.   PERFUSION-UK

Activation of the Hemostatic System During Cardiopulmonary Bypass

(2011) Roman M. Sniecinski et al.   ANESTHESIA AND ANALGESIA

Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding

(2011) A. S. Revenko et al.   BLOOD

Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin

(2011) J. Konings et al.   BLOOD

Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In Vivo

(2011) Chris Oschatz et al.   IMMUNITY

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo

(2010) Q. Cheng et al.   BLOOD

Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice

(2010) R. Pawlinski et al.   BLOOD

Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis

(2010) G. A. LaRusch et al.   BLOOD

Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin

(2010) N. J. Mutch et al.   BLOOD

Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding

(2010) Ina Hagedorn et al.   CIRCULATION

New Anticoagulants

(2010) John W. Eikelboom et al.   CIRCULATION

Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis

(2010) Ophira Salomon et al.   THROMBOSIS AND HAEMOSTASIS

Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis

(2010) Misaki Takahashi et al.   THROMBOSIS RESEARCH

Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo

(2009) Felicitas Müller et al.   CELL

Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation

(2009) Yanming Wang et al.   JOURNAL OF CELL BIOLOGY

Ir-CPI, a coagulation contact phase inhibitor from the tickIxodes ricinus, inhibits thrombus formation without impairing hemostasis

(2009) Yves Decrem et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

(2008) E. I. Tucker et al.   BLOOD

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

(2008) O. Salomon et al.   BLOOD

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

(2008) Sam Schulman et al.   CHEST

Triggers, targets and treatments for thrombosis

(2008) Nigel Mackman   NATURE